Trials / Conditions / Severe Persistent Asthma

Severe Persistent Asthma

13 registered clinical trials studyying Severe Persistent Asthma.

Status	Trial	Sponsor	Phase
Completed	Project 2 Airway Potential Hydrogen (pH) in Asthma NCT03617718	Case Western Reserve University	Phase 1 / Phase 2
Withdrawn	Expressions of TRPV1 in Airway of Asthmatics NCT02952066	Lu Yuan Lee	N/A
Completed	Identification of Serum Biomarkers for CD15+ Hypodense Neutrophils in Severe Asthma NCT02659618	Rush University Medical Center	—
Completed	A Pragmatic Trial of Corticosteroid Optimisation in Severe Asthma NCT02717689	Belfast Health and Social Care Trust	N/A
Completed	Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma NCT02559791	McMaster University	Phase 2 / Phase 3
Completed	Prevalence of Hyperventilation Syndrome in Difficult Asthma NCT01862289	Assistance Publique - Hôpitaux de Paris	N/A
Completed	Bronchial Thermoplasty: Effect on Neuronal and Chemosensitive Component of the Bronchial Mucosa NCT01839591	Azienda USL Reggio Emilia - IRCCS	N/A
Completed	Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma NCT01748175	Sally E. Wenzel MD	—
Withdrawn	Bronchoscopy Study for Severe Asthma NCT01745809	University of Pennsylvania	—
Completed	Severe Asthma Research Program - Wake Forest University NCT01750411	Wake Forest University	—
Terminated	Inhaled Steroids and Control of Severe Asthma NCT01197482	University of Giessen	—
Withdrawn	A National Program for Severe Asthma: The Canadian Severe Asthma Network NCT00954850	University of Alberta	—
Withdrawn	Evaluation of Lovastatin in Severe Persistent Asthma NCT00689806	University of Chicago	Phase 1 / Phase 2